ConcertAI, a leader in oncology predictive and generative AI SaaS solutions and real-world data for healthcare and life sciences, has announced the addition of Dhiraj Carumbaya as Senior Vice President and General Manager of the company’s TeraRecon business. This strategic hire aims to bolster ConcertAI’s advanced visualization solutions and generative AI innovations in medical imaging and clinical research.
- Dhiraj Carumbaya’s Experience and Role
- Over two decades of experience in Medical Imaging, Healthcare Informatics, and Clinical AI.
- Will lead ConcertAI’s Intuition™ advanced visualization solution and Eureka™ Clinical AI.
- Focus on imaging data solutions and advanced Generative AI for imaging interpretation and clinical research.
- Leadership and Vision
- Jeff Elton, PhD, CEO of ConcertAI, highlights Dhiraj’s suitability for the role due to his depth in imaging, SaaS technologies, and AI.
- The goal is to ensure provider and biopharma partners have access to advanced technologies and data.
- Future benefits include advancements in precision oncology and integration of CARAai platform with TeraRecon expertise.
- Career Highlights
- Started in medical physics and advanced through roles at RadNet, Philips Healthcare, Amazon AWS, GE Healthcare, and Fujifilm.
- At Philips, doubled the Radiology Informatics business in two years.
- At AWS, developed and scaled next-gen cloud solutions for healthcare and life sciences.
- Consulted for the US Government’s Accountability Office in Healthcare IT.
- Impact of Generative AI
- Generative AI in medical imaging automates the segmentation of biomarkers, like tumors, from high-fidelity medical images.
- This innovation is transformative for healthcare providers and the biopharma industry.
- Dhiraj expresses excitement to lead TeraRecon into a new growth phase, bringing innovations to medical diagnosis, clinical research, and drug development.
Dhiraj Carumbaya’s extensive background and expertise in medical imaging and AI make him an invaluable addition to ConcertAI. His leadership is expected to drive significant advancements in AI-driven medical imaging and research, enhancing the capabilities and offerings of ConcertAI’s TeraRecon business. The infusion of generative AI will further elevate the precision and efficiency of medical diagnostics and research, benefiting healthcare providers and the biopharma industry.